226 related articles for article (PubMed ID: 36810011)
1. Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Ishay A; Shacham EC
BMC Endocr Disord; 2023 Feb; 23(1):47. PubMed ID: 36810011
[TBL] [Abstract][Full Text] [Related]
2. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
[TBL] [Abstract][Full Text] [Related]
3. A Case of Hypophysitis Associated With SARS-CoV-2 Vaccination.
Ankireddypalli AR; Chow LS; Radulescu A; Kawakami Y; Araki T
AACE Clin Case Rep; 2022; 8(5):204-209. PubMed ID: 35754921
[TBL] [Abstract][Full Text] [Related]
4. Transient Central Diabetes Insipidus (Arginine Vasopressin Deficiency) Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.
Mazzeo P; Ceccato F; Manara R; Mazzon C; Barbot M
Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38243973
[TBL] [Abstract][Full Text] [Related]
5. Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report.
Bouça B; Roldão M; Bogalho P; Cerqueira L; Silva-Nunes J
Front Endocrinol (Lausanne); 2022; 13():889074. PubMed ID: 35600593
[TBL] [Abstract][Full Text] [Related]
6. Bilateral Optic Neuritis and Hypophysitis With Diabetes Insipidus 1 Month After COVID-19 mRNA Vaccine: Case Report and Literature Review.
Matsuo T; Okubo K; Mifune H; Imao T
J Investig Med High Impact Case Rep; 2023; 11():23247096231186046. PubMed ID: 37431875
[TBL] [Abstract][Full Text] [Related]
7. Central diabetes insipidus secondary to COVID-19 infection: a case report.
Yavari A; Sharifan Z; Larijani B; Mosadegh Khah A
BMC Endocr Disord; 2022 May; 22(1):134. PubMed ID: 35590312
[TBL] [Abstract][Full Text] [Related]
8. Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology.
Taieb A; Mounira EE
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560413
[TBL] [Abstract][Full Text] [Related]
9. Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report.
Morita S; Tsuji T; Kishimoto S; Uraki S; Takeshima K; Iwakura H; Furuta H; Nishi M; Inaba H; Matsuoka TA
BMC Endocr Disord; 2022 Jul; 22(1):185. PubMed ID: 35854260
[TBL] [Abstract][Full Text] [Related]
10. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
Front Public Health; 2021; 9():778964. PubMed ID: 34888290
[No Abstract] [Full Text] [Related]
11. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination.
Aydoğan Bİ; Ünlütürk U; Cesur M
Endocrine; 2022 Oct; 78(1):42-46. PubMed ID: 35809159
[TBL] [Abstract][Full Text] [Related]
12. A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine.
Murvelashvili N; Tessnow A
J Investig Med High Impact Case Rep; 2021; 9():23247096211043386. PubMed ID: 34553641
[TBL] [Abstract][Full Text] [Related]
13. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.
Misgar RA; Rasool A; Wani AI; Bashir MI
J Endocrinol Invest; 2021 Dec; 44(12):2855-2856. PubMed ID: 34215999
[No Abstract] [Full Text] [Related]
14. Coronavirus as a trigger of lymphocytic hypophysitis in an adolescent girl: An exceptional case report.
Zerrouki D; Assarrar I; Rami I; Rouf S; Latrech H
Int J Surg Case Rep; 2024 Feb; 115():109218. PubMed ID: 38199020
[TBL] [Abstract][Full Text] [Related]
15. Central Diabetes Insipidus Due to IgG4-related Hypophysitis That Required over One Year to Reach the Final Diagnosis Due to Symptoms Being Masked by Sialadenitis.
Iwamoto Y; Mori S; Tatsumi F; Sugisaki T; Dan K; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Mune T; Kaneto H
Intern Med; 2022 Dec; 61(23):3541-3545. PubMed ID: 35569983
[TBL] [Abstract][Full Text] [Related]
16. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature.
Takedani K; Notsu M; Ishiai N; Asami Y; Uchida K; Kanasaki K
BMC Endocr Disord; 2023 Jun; 23(1):132. PubMed ID: 37316819
[TBL] [Abstract][Full Text] [Related]
18. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
[TBL] [Abstract][Full Text] [Related]
19. Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.
Dubinski I; Bechtold-Dalla Pozza S; Schmidt H
J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1544-1546. PubMed ID: 36240057
[TBL] [Abstract][Full Text] [Related]
20. Secondary autoimmune hypothalamitis with severe memory impairment 7 years after the onset of diabetes insipidus due to lymphocytic hypophysitis: a case report.
Asada T; Takenoshita S; Senda M; Yamamoto K; Sasaki R; Otsuka F; Terada S; Yamada N
BMC Neurol; 2022 Sep; 22(1):371. PubMed ID: 36175850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
